Clinical Trials Sponsored by SOLTI Breast Cancer Research Group
Total 978 results
-
SOLTI Breast Cancer Research GroupRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-negative Breast CancerSpain
-
SOLTI Breast Cancer Research GroupTerminated
-
SOLTI Breast Cancer Research GroupCompleted
-
SOLTI Breast Cancer Research GroupNot yet recruitingBreast Cancer Stage IVSpain
-
SOLTI Breast Cancer Research GroupRecruitingBreast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Premenopausal Breast CancerSpain
-
SOLTI Breast Cancer Research GroupCompletedMetastatic Breast CancerSpain
-
SOLTI Breast Cancer Research GroupTerminated
-
SOLTI Breast Cancer Research GroupCompleted
-
SOLTI Breast Cancer Research GroupCompleted
-
SOLTI Breast Cancer Research GroupNovartisRecruitingMelanoma | Sarcoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Uterine Carcinosarcoma | Mesothelioma | Cholangiocarcinoma | Lung Adenocarcinoma | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal... and other conditionsSpain
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
SOLTI Breast Cancer Research GroupPfizerCompleted
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
SanofiSOLTI Breast Cancer Research GroupCompletedBreast Cancer FemaleSpain, France, Germany
-
SOLTI Breast Cancer Research GroupNovartis; UNICANCERRecruitingBreast Cancer Stage IISpain, France, Portugal
-
SOLTI Breast Cancer Research GroupEisai Inc.CompletedBreast CancerSpain, France, Portugal, Germany
-
SOLTI Breast Cancer Research GroupSchering-PloughCompleted
-
Genentech, Inc.SOLTI Breast Cancer Research GroupCompletedBreast CancerUnited States, Spain, Portugal
-
Oncolytics BiotechSOLTI Breast Cancer Research GroupTerminated
-
Novartis PharmaceuticalsBreast International Group; SOLTI Breast Cancer Research GroupCompletedNeoplasms, BreastFrance, Spain, United Kingdom, Belgium, Argentina, Czechia, Germany, Italy, Norway, Russian Federation, Sweden, Taiwan, Hong Kong, Brazil, Hungary, India, Korea, Republic of, Pakistan, Peru, Romania, South Africa, Ukraine, Canada, Lit...
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
UNICANCERARCAGY/ GINECO GROUP; SOLTI Breast Cancer Research GroupActive, not recruitingER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer | a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI StatusFrance
-
Fundacio Clinic BarcelonaSOLTI Breast Cancer Research GroupNot yet recruitingMetastatic Triple-Negative Breast CarcinomaSpain
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruiting
-
SOLTI Breast Cancer Research GroupDaiichi Sankyo, Inc.Active, not recruiting
-
SOLTI Breast Cancer Research GroupPierre Fabre LaboratoriesCompleted
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruitingMetastatic Breast CancerSpain
-
SOLTI Breast Cancer Research GroupDaiichi Sankyo, Inc.Active, not recruiting
-
SOLTI Breast Cancer Research GroupRadius Health, Inc.CompletedBreast Cancer | Hormone Receptor Positive Breast CarcinomaSpain
-
SOLTI Breast Cancer Research GroupSysmex America, Inc.Completed
-
SOLTI Breast Cancer Research GroupDaiichi Sankyo, Inc.Recruiting
-
Genentech, Inc.Breast International Group; SOLTI Breast Cancer Research Group; Austrian Breast...CompletedBreast CancerUnited States, United Kingdom, Germany, Australia, Austria, Belgium, Brazil, France, Guatemala, Italy, Korea, Republic of, Panama, Poland, Portugal, Spain, Czechia, Hungary, Mexico, Peru, Switzerland, El Salvador, Chile
-
SOLTI Breast Cancer Research GroupMerck Sharp & Dohme LLCActive, not recruiting
-
SOLTI Breast Cancer Research GroupRoche Pharma AG; AmgenActive, not recruiting
-
SOLTI Breast Cancer Research GroupNovartis; Alliance Foundation Trials, LLC.RecruitingMetastatic Breast CancerUnited States, Spain, Portugal
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
SOLTI Breast Cancer Research GroupNovartis; Roche Pharma AG; Guardant Health, Inc.Active, not recruitingMetastatic Breast CancerSpain
-
UNICANCERSOLTI Breast Cancer Research Group; Vall d'Hebron Institute of Oncology; MSD...Not yet recruitingTriple-negative Breast Cancer
-
SOLTI Breast Cancer Research GroupDana-Farber Cancer Institute; Novartis Pharmaceuticals; Stand Up To CancerCompletedBreast CancerUnited States, Spain
-
Spanish Breast Cancer Research GroupActive, not recruitingMetastatic Breast CancerSpain
-
Spanish Breast Cancer Research GroupCompleted
-
Spanish Breast Cancer Research GroupRecruiting
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; German Breast GroupCompletedBreast CancerSpain, Germany
-
Lund University HospitalDanish Breast Cancer Cooperative Group; Swedish Breast Cancer Group; Finnish... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast NeoplasmsDenmark, Sweden
-
Spanish Breast Cancer Research GroupSanofiCompleted
-
Spanish Breast Cancer Research GroupNovartisCompleted
-
Spanish Breast Cancer Research GroupNovartisCompletedBreast Cancer | Neoplasm MetastasisSpain
-
Spanish Breast Cancer Research GroupAstraZenecaCompleted
-
Spanish Breast Cancer Research GroupAstraZenecaActive, not recruitingBreast NeoplasmsSpain, Ireland